Quinones are a class
of cyclic organic compounds that are widely
distributed in nature and have been shown to exhibit anti-inflammatory,
antioxidant, and anticancerous activities. However, the molecular
mechanisms/signaling by which these molecules exert their effect are
still not fully understood. In this study, a group of quinone-derived
compounds were examined for their potential inhibitory effect against
human IRAK1 and IRAK4 kinases in vitro. We have identified
five compounds: 1,4-naphthoquinone, emodin, shikonin, plumbagin, and
menadione (vitamin K3) as active and selective inhibitors of human
IRAK1 enzyme in vitro. The biochemical binding and
molecular interactions between the active compounds and IRAK1’s
catalytic site were demonstrated in silico using
structural-based docking and dynamic simulation analysis. Also, 1,4-naphthoquinone
was found to effectively inhibit the growth of cancer cell lines overexpressing
IRAK1. Furthermore, 1,4-naphthoquinone potently suppressed the production
and secretion of key proinflammatory cytokine proteins IL-8, IL-1β,
IL-10, TNF-α, and IL-6 in LPS-stimulated PMA-induced human THP-1
macrophages. In conclusion, 1,4-naphthoquinone is an effective inhibitor
of IRAK1 kinases and their mediated inflammatory cytokines production
in LPS-stimulated PMA-induced human THP-1 macrophages.